Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
Clinical trial NCT03802604 · COMPLETED
Trial details
- NCT number
- NCT03802604
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-10
- Primary completion
- 2022-04-27
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.